|
|
||||||||
The Journal of Immunology, Vol 147, Issue 9 2991-3000, Copyright © 1991 by American Association of Immunologists
ARTICLES |
SL Swain, G Huston, S Tonkonogy and A Weinberg
Department of Biology, University of California, San Diego, La Jolla 92093.
We have investigated the effects of TGF-beta on the in vitro development of different subsets of Th cells and find that addition of TGF-beta results in the generation of cell populations with distinct characteristics that resemble those of memory cells. Resting, short- lived CD4+ precursor T cells can be induced by mitogen stimulation to proliferate and differentiate in in vitro cultures and after 4 to 7 days will generate a population of cells that, when restimulated, synthesize and secrete high titers of a wide variety of lymphokines. It has been previously reported that the presence of the lymphokine IL-4 during in vitro culture results in the generation of a population of "effector" cells that can be rapidly induced by mitogen to synthesize and secrete high titers of IL-4, IL-5, IL-3, IFN-gamma, and granulocyte- macrophage-CSF. We find that TGF-beta added to CD4+ precursors, suppresses the development of IL-4/IL-5 secreting effectors and results instead in the development of cells secreting IL-2 and IFN-gamma. CD4 T cells generated in the presence of TGF-beta show little or no expression of CD45RB, in contrast to those developed in IL-4 (or in IL- 2 alone) that express high surface densities of CD45RB. The kinetics of cell recovery also differs when TGF-beta rather than IL-4 is present during culture. Cultures of effectors generated in TGF-beta, initially have low cell recoveries but cells expand dramatically between 4 to 7 days in the presence of IL-2 whereas IL-4 induces optimum cell recovery at day 4 and cell recoveries decrease with further culture. The properties of cells grown in TGF-beta thus show several attributes in common with memory or highly differentiated CD4+ cells, i.e., IL-2 as a predominant cytokine, easy propagation and low expression of CD45RB. Therefore, we propose the hypothesis that TGF-beta favors the development of a population(s) of Th cells that is likely to give rise to memory cells although IL-4 favors development of a short-lived effector population that secretes Th2 lymphokines.
This article has been cited by other articles:
![]() |
M. M. Hauri-Hohl, S. Zuklys, M. P. Keller, L. T. Jeker, T. Barthlott, A. M. Moon, J. Roes, and G. A. Hollander TGF-{beta} signaling in thymic epithelial cells regulates thymic involution and postirradiation reconstitution Blood, August 1, 2008; 112(3): 626 - 634. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Thakkinstian, S. Dmitrienko, M. Gerbase-DeLima, D. O. McDaniel, P. Inigo, K. M. Chow, M. McEvoy, A. Ingsathit, P. Trevillian, W. H. Barber, et al. Association between cytokine gene polymorphisms and outcomes in renal transplantation: a meta-analysis of individual patient data Nephrol. Dial. Transplant., April 17, 2008; (2008) gfn185v3. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-L. Cheng, H.-W. Chen, J.-P. Tsai, Y.-P. Lee, Y.-C. Shih, C.-M. Chang, and C.-C. Ting Clonal restriction of the expansion of antigen-specific CD8+ memory T cells by transforming growth factor-{beta} J. Leukoc. Biol., May 1, 2006; 79(5): 1033 - 1042. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Leveen, M. Carlsen, A. Makowska, S. Oddsson, J. Larsson, M.-J. Goumans, C. M. Cilio, and S. Karlsson TGF-{beta} type II receptor-deficient thymocytes develop normally but demonstrate increased CD8+ proliferation in vivo Blood, December 15, 2005; 106(13): 4234 - 4240. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ahmadzadeh and S. A. Rosenberg TGF-{beta}1 Attenuates the Acquisition and Expression of Effector Function by Tumor Antigen-Specific Human Memory CD8 T Cells J. Immunol., May 1, 2005; 174(9): 5215 - 5223. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Lucas, N. McNeil, E. Hilgenfeld, B. Choudhury, S.-J. Kim, M. A. Eckhaus, T. Ried, and R. E. Gress Transforming Growth Factor-{beta} Pathway Serves as a Primary Tumor Suppressor in CD8+ T Cell Tumorigenesis Cancer Res., September 15, 2004; 64(18): 6524 - 6529. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. McKarns, R. H. Schwartz, and N. E. Kaminski Smad3 Is Essential for TGF-{beta}1 to Suppress IL-2 Production and TCR-Induced Proliferation, but Not IL-2-Induced Proliferation J. Immunol., April 1, 2004; 172(7): 4275 - 4284. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. L. Oleszak, J. R. Chang, H. Friedman, C. D. Katsetos, and C. D. Platsoucas Theiler's Virus Infection: a Model for Multiple Sclerosis Clin. Microbiol. Rev., January 1, 2004; 17(1): 174 - 207. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Lund, T. Aittokallio, O. Nevalainen, and R. Lahesmaa Identification of Novel Genes Regulated by IL-12, IL-4, or TGF-{beta} during the Early Polarization of CD4+ Lymphocytes J. Immunol., November 15, 2003; 171(10): 5328 - 5336. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Xu, P. B. Silver, T. K. Tarrant, C.-C. Chan, and R. R. Caspi TGF-{beta} Inhibits Activation and Uveitogenicity of Primary but Not of Fully Polarized Retinal Antigen-Specific Memory-Effector T Cells Invest. Ophthalmol. Vis. Sci., November 1, 2003; 44(11): 4805 - 4812. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. J. Barrat, D. J. Cua, A. Boonstra, D. F. Richards, C. Crain, H. F. Savelkoul, R. de Waal-Malefyt, R. L. Coffman, C. M. Hawrylowicz, and A. O'Garra In Vitro Generation of Interleukin 10-producing Regulatory CD4+ T Cells Is Induced by Immunosuppressive Drugs and Inhibited by T Helper Type 1 (Th1)- and Th2-inducing Cytokines J. Exp. Med., March 4, 2002; 195(5): 603 - 616. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Saverino, A. Merlo, S. Bruno, V. Pistoia, C. E. Grossi, and E. Ciccone Dual Effect of CD85/Leukocyte Ig-Like Receptor-1/Ig-Like Transcript 2 and CD152 (CTLA-4) on Cytokine Production by Antigen-Stimulated Human T Cells J. Immunol., January 1, 2002; 168(1): 207 - 215. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Cottrez and H. Groux Regulation of TGF-{{beta}} Response During T Cell Activation Is Modulated by IL-10 J. Immunol., July 15, 2001; 167(2): 773 - 778. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Gorham, J. T. Lin, J. L. Sung, L. A. Rudner, and M. A. French Genetic Regulation of Autoimmune Disease: BALB/c Background TGF-{{beta}}1-Deficient Mice Develop Necroinflammatory IFN-{{gamma}}-Dependent Hepatitis J. Immunol., May 15, 2001; 166(10): 6413 - 6422. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. K. Levings, R. Sangregorio, F. Galbiati, S. Squadrone, R. de Waal Malefyt, and M.-G. Roncarolo IFN-{{alpha}} and IL-10 Induce the Differentiation of Human Type 1 T Regulatory Cells J. Immunol., May 1, 2001; 166(9): 5530 - 5539. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Gorelik, P. E. Fields, and R. A. Flavell Cutting Edge: TGF-{beta} Inhibits Th Type 2 Development Through Inhibition of GATA-3 Expression J. Immunol., November 1, 2000; 165(9): 4773 - 4777. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. H. Little, G. M. Georgiou, A. Marceglia, H. Ogedgebe, R. E. Cone, and D. Mazza Measurement of T-Cell-Derived Antigen Binding Molecules and Immunoglobulin G Specific to Candida albicans Mannan in Sera of Patients with Recurrent Vulvovaginal Candidiasis Infect. Immun., July 1, 2000; 68(7): 3840 - 3847. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kato and H. Nariuchi Polarization of Naive CD4+ T Cells Toward the Th1 Subset by CTLA-4 Costimulation J. Immunol., April 1, 2000; 164(7): 3554 - 3562. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Vukmanovic-Stejic, B. Vyas, P. Gorak-Stolinska, A. Noble, and D. M. Kemeny Human Tc1 and Tc2/Tc0 CD8 T-cell clones display distinct cell surface and functional phenotypes Blood, January 1, 2000; 95(1): 231 - 240. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ahmadzadeh, S. F. Hussain, and D. L. Farber Effector CD4 T Cells Are Biochemically Distinct from the Memory Subset: Evidence for Long-Term Persistence of Effectors In Vivo J. Immunol., September 15, 1999; 163(6): 3053 - 3063. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. W. v. Ginkel, S. M. Wahl, J. F. Kearney, M.-N. Kweon, K. Fujihashi, P. D. Burrows, H. Kiyono, and J. R. McGhee Partial IgA-Deficiency with Increased Th2-Type Cytokines in TGF-{beta}1 Knockout Mice J. Immunol., August 15, 1999; 163(4): 1951 - 1957. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. TILLIE-LEBLOND, J. PUGIN, C.-H. MARQUETTE, C. LAMBLIN, F. SAULNIER, A. BRICHET, B. WALLAERT, A.-B. TONNEL, and P. GOSSET Balance between Proinflammatory Cytokines and Their Inhibitors in Bronchial Lavage from Patients with Status Asthmaticus Am. J. Respir. Crit. Care Med., February 1, 1999; 159(2): 487 - 494. [Abstract] [Full Text] |
||||
![]() |
M. L. Guler, J. D. Gorham, W. F. Dietrich, T. L. Murphy, R. G. Steen, C. A. Parvin, D. Fenoglio, A. Grupe, G. Peltz, and K. M. Murphy Tpm1, a Locus Controlling IL-12 Responsiveness, Acts by a Cell-Autonomous Mechanism J. Immunol., February 1, 1999; 162(3): 1339 - 1347. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Genestier, S. Kasibhatla, T. Brunner, and D. R. Green Transforming Growth Factor beta 1 Inhibits Fas Ligand Expression and Subsequent Activation-induced Cell Death in T Cells via Downregulation of c-Myc J. Exp. Med., January 18, 1999; 189(2): 231 - 239. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Li, C. A. Hunter, and J. P. Farrell Anti-TGF-{beta} Treatment Promotes Rapid Healing of Leishmania major Infection in Mice by Enhancing In Vivo Nitric Oxide Production J. Immunol., January 15, 1999; 162(2): 974 - 979. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. E. Boursalian and K. Bottomly Stability of Naive and Memory Phenotypes on Resting CD4 T Cells In Vivo J. Immunol., January 1, 1999; 162(1): 9 - 16. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. Han, S. S. Yea, Y. J. Jeon, K.-H. Yang, and N. E. Kaminski Transforming Growth Factor-Beta 1 (TGF-beta 1) Promotes IL-2 mRNA Expression Through the Up-regulation of NF-kappa B, AP-1 and NF-AT in EL4 Cells J. Pharmacol. Exp. Ther., December 1, 1998; 287(3): 1105 - 1112. [Abstract] [Full Text] |
||||
![]() |
W. Chen, W. Jin, and S. M. Wahl Engagement of Cytotoxic T Lymphocyte-associated Antigen 4 (CTLA-4) Induces Transforming Growth Factor beta (TGF-beta ) Production by Murine CD4+ T Cells J. Exp. Med., November 16, 1998; 188(10): 1849 - 1857. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Lingnau, P. Hoehn, S. Kerdine, S. Koelsch, C. Neudoerfl, N. Palm, E. Ruede, and E. Schmitt IL-4 in Combination with TGF-{beta} Favors an Alternative Pathway of Th1 Development Independent of IL-12 J. Immunol., November 1, 1998; 161(9): 4709 - 4718. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Gorham, M. L. Guler, D. Fenoglio, U. Gubler, and K. M. Murphy Low Dose TGF-{beta} Attenuates IL-12 Responsiveness in Murine Th Cells J. Immunol., August 15, 1998; 161(4): 1664 - 1670. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Seder, T. Marth, M. C. Sieve, W. Strober, J. J. Letterio, A. B. Roberts, and B. Kelsall Factors Involved in the Differentiation of TGF-{beta}-Producing Cells from Naive CD4+ T Cells: IL-4 and IFN-{gamma} Have Opposing Effects, While TGF-{beta} Positively Regulates Its Own Production J. Immunol., June 15, 1998; 160(12): 5719 - 5728. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. T. Miner and M. Croft Generation, Persistence, and Modulation of Th0 Effector Cells: Role of Autocrine IL-4 and IFN-{gamma} J. Immunol., June 1, 1998; 160(11): 5280 - 5287. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Bohn, E. Schmitt, C. Bielfeldt, A. Noll, R. Schulte, and I. B. Autenrieth Ambiguous Role of Interleukin-12 in Yersinia enterocolitica Infection in Susceptible and Resistant Mouse Strains Infect. Immun., May 1, 1998; 66(5): 2213 - 2220. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Takeuchi, P. Alard, and J. W. Streilein TGF-{beta} Promotes Immune Deviation by Altering Accessory Signals of Antigen-Presenting Cells J. Immunol., February 15, 1998; 160(4): 1589 - 1597. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Zhang, T. Brunner, L. Carter, R. W. Dutton, P. Rogers, L. Bradley, T. Sato, J. C. Reed, D. Green, and S. L. Swain Unequal Death in T Helper Cell (Th)1 and Th2 Effectors: Th1, but not Th2, Effectors Undergo Rapid Fas/FasL-mediated Apoptosis J. Exp. Med., May 19, 1997; 185(10): 1837 - 1849. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. M. Conboy, R. H. DeKruyff, K. M. Tate, Z. A. Cao, T. A. Moore, D. T. Umetsu, and P. P. Jones Novel Genetic Regulation of T Helper 1 (Th1)/Th2 Cytokine Production and Encephalitogenicity in Inbred Mouse Strains J. Exp. Med., February 3, 1997; 185(3): 439 - 452. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Hsieh, S. Macatonia, C. Tripp, S. Wolf, A O'Garra, and K. Murphy Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages Science, April 23, 1993; 260(5107): 547 - 549. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |